Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

791
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
791
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distribution and morphological variation of septoclasts during mouse cranial base development.

Journal of anatomy·2026
Same author

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.

Nature cancer·2026
Same author

Effects of an indole chemical, mitochonic acid 5, in a mouse model of mitochondrial disease onset.

Scientific reports·2026
Same author

Maternal fasting during early gestation induces epigenetic alterations and schizophrenia-related phenotypes.

Molecular psychiatry·2026
Same author

Evaluation of Data-Independent Acquisition-Based Phosphoproteomics Analysis in Mammalian and Bacterial Systems.

Journal of proteome research·2026
Same author

Unpredictable Chronic Mild Stress Upregulates Dopamine Receptor Expression Independent of Fatty Acid-Binding Protein 7 Gene Deletion.

Neurochemical research·2026

Related Experiment Video

Updated: Jan 9, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K

Astrocyte FABP7 Modulates Seizure Activity-Dependent Protein Expression in Mouse Brain.

Adam P Berg1, Shahroz H Tariq1, Carlos C Flores1

  • 1Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99202, USA.

Neuroglia (Basel, Switzerland)
|December 5, 2025
PubMed
Summary
This summary is machine-generated.

The astrocyte factor brain-type fatty acid binding protein (Fabp7) influences seizure activity by modulating proteasomal pathways. This study reveals Fabp7

Keywords:
blbpglialipid signalingneural excitabilityprotein translationproteomics

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.5K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.9K

Related Experiment Videos

Last Updated: Jan 9, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.5K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.9K

Area of Science:

  • Neuroscience and molecular biology
  • Astrocyte biology and epilepsy research

Background:

  • Epilepsy seizure patterns often correlate with sleep-wake cycles or diurnal rhythms.
  • Astrocytes, non-neuronal cells, may play a role in the cellular and molecular mechanisms of these seizure patterns.
  • Brain-type fatty acid binding protein (Fabp7) is a key astrocyte factor regulating seizure threshold and gene expression.

Purpose of the Study:

  • To investigate the influence of Fabp7 on differential seizure activity-dependent protein expression.
  • To compare protein expression in Fabp7 knockout (KO) mice versus wild-type (WT) mice.
  • To analyze proteomic changes under control conditions and after maximal electroshock seizure threshold (MEST) induction.

Main Methods:

  • Proteomic analysis of cortical-hippocampal extracts from WT and Fabp7 KO mice.
  • Utilized mass spectrometry (MS) for protein identification.
  • Performed Gene Ontology (GO) and pathway analyses on differentially expressed proteins (DEPs).

Main Results:

  • Identified 65 DEPs in KO SHAM vs. WT SHAM, with 33 upregulated and 32 downregulated.
  • Observed downregulation of mitochondrial-associated proteins in WT MEST vs. WT SHAM.
  • Found elevated proteasomal activity in Fabp7-deficient mice, indicated by upregulated DEPs associated with the 20S proteasomal subunit.

Conclusions:

  • Astrocyte Fabp7 modulates time-of-day-mediated neural excitability.
  • This modulation involves multiple cellular mechanisms, including proteasomal pathways.
  • These effects are independent of Fabp7's previously identified role in activity-dependent gene expression.